View in EDS HTML Full Text PDF Full Text

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.

Saved in:
Bibliographic Details
Title: Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
Authors: Martínez-Casanova J; Pharmacy Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain., Esteve-Pitarch E; Pharmacy Department, Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain., Colom-Codina H; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain.; Pharmacy and Pharmaceutical Technology and Physical Chemistry Department, Universitat de Barcelona, 08028 Barcelona, Spain., Gumucio-Sanguino VD; Critical Care Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain., Cobo-Sacristán S; Pharmacy Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain., Shaw E; Infectious Diseases Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Epidemiologia de les Infeccions Bacterianes, Patologia Infecciosa i Transplantament, Institut d'Investigacio Biomedica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Maisterra-Santos K; Critical Care Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain., Sabater-Riera J; Critical Care Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain., Pérez-Fernandez XL; Critical Care Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain., Rigo-Bonnin R; Clinical Laboratory Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain., Tubau-Quintano F; Department of Microbiology, Hospital Universitari de Bellvitge-IDIBELL, 08907 Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain., Carratalà J; Infectious Diseases Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Campus Ciencias de la Salud de Bellvitge, University of Barcelona, 08907 Hospitalet de Llobregat, Spain., Padullés-Zamora A; Pharmacy Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Source: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2023 Mar 07; Vol. 12 (3). Date of Electronic Publication: 2023 Mar 07.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101637404 Publication Model: Electronic Cited Medium: Print ISSN: 2079-6382 (Print) Linking ISSN: 20796382 NLM ISO Abbreviation: Antibiotics (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36978398
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martínez-Casanova+J%22">Martínez-Casanova J</searchLink>; Pharmacy Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Esteve-Pitarch+E%22">Esteve-Pitarch E</searchLink>; Pharmacy Department, Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain.<br /><searchLink fieldCode="AU" term="%22Colom-Codina+H%22">Colom-Codina H</searchLink>; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain.; Pharmacy and Pharmaceutical Technology and Physical Chemistry Department, Universitat de Barcelona, 08028 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gumucio-Sanguino+VD%22">Gumucio-Sanguino VD</searchLink>; Critical Care Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Cobo-Sacristán+S%22">Cobo-Sacristán S</searchLink>; Pharmacy Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Shaw+E%22">Shaw E</searchLink>; Infectious Diseases Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Epidemiologia de les Infeccions Bacterianes, Patologia Infecciosa i Transplantament, Institut d'Investigacio Biomedica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Maisterra-Santos+K%22">Maisterra-Santos K</searchLink>; Critical Care Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Sabater-Riera+J%22">Sabater-Riera J</searchLink>; Critical Care Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Fernandez+XL%22">Pérez-Fernandez XL</searchLink>; Critical Care Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Rigo-Bonnin+R%22">Rigo-Bonnin R</searchLink>; Clinical Laboratory Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Tubau-Quintano+F%22">Tubau-Quintano F</searchLink>; Department of Microbiology, Hospital Universitari de Bellvitge-IDIBELL, 08907 Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Carratalà+J%22">Carratalà J</searchLink>; Infectious Diseases Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Campus Ciencias de la Salud de Bellvitge, University of Barcelona, 08907 Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Padullés-Zamora+A%22">Padullés-Zamora A</searchLink>; Pharmacy Department, Hospital Universitari de Bellvitge, 08907 Hospitalet de Llobregat, Spain.; Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101637404%22">Antibiotics (Basel, Switzerland)</searchLink> [Antibiotics (Basel)] 2023 Mar 07; Vol. 12 (3). <i>Date of Electronic Publication: </i>2023 Mar 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101637404 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2079-6382 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220796382%22">20796382 </searchLink><i>NLM ISO Abbreviation: </i>Antibiotics (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36978398
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/antibiotics12030531
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martínez-Casanova J
      – PersonEntity:
          Name:
            NameFull: Esteve-Pitarch E
      – PersonEntity:
          Name:
            NameFull: Colom-Codina H
      – PersonEntity:
          Name:
            NameFull: Gumucio-Sanguino VD
      – PersonEntity:
          Name:
            NameFull: Cobo-Sacristán S
      – PersonEntity:
          Name:
            NameFull: Shaw E
      – PersonEntity:
          Name:
            NameFull: Maisterra-Santos K
      – PersonEntity:
          Name:
            NameFull: Sabater-Riera J
      – PersonEntity:
          Name:
            NameFull: Pérez-Fernandez XL
      – PersonEntity:
          Name:
            NameFull: Rigo-Bonnin R
      – PersonEntity:
          Name:
            NameFull: Tubau-Quintano F
      – PersonEntity:
          Name:
            NameFull: Carratalà J
      – PersonEntity:
          Name:
            NameFull: Padullés-Zamora A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 03
              Text: 2023 Mar 07
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2079-6382
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Antibiotics (Basel, Switzerland)
              Type: main
ResultId 1